DENISE SMITH: Open Payments
NPI 1962920785 · CONNERSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 19 payments from 6 companies in 2025. Trend: 2023 $283 · 2024 $430 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $136 |
| Otsuka America Pharmaceutical, Inc. | 3 | $101 |
| ABBVIE INC. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Corium, LLC | 2 | $27 |
Products named: CAPLYTA, REXULTI, INGREZZA, FANAPT, VRAYLAR, Azstarys, UBRELVY, QULIPTA.
Industry payments across IN — which companies pay providers there.
